Sponsored Content
Discover how Sabinsa’s curcuminoid innovation C3 Reduct® can deliver health and formulation benefits
23 Nov 2022Sabinsa has developed Curcumin C3 Reduct®, the only reductive metabolites of curcuminoids on the market to have been approved as a Novel Food by the European Food Safety Authority (EFSA). Easy to integrate into existing production processes and with the concentrated benefits of curcumin, C3 Reduct® has been shown to boost organ health and deliver a range of other targeted functionalities.
This makes it ideal to help product developers meet consumer health and wellness expectations – and open up new market opportunities.
Curcumin, the principal curcuminoid sourced from the spice turmeric, has gained increasing global recognition for its multiple health benefits, in particular its antioxidant and anti-inflammatory properties. As a result, the ingredient is used as a means of supporting healthy living and longevity, and in managing inflammation and joint soreness.
A principal advantage of C3 Reduct® is that these benefits are concentrated and enhanced. C3 Reduct ®, wherein curcuminoids are already converted to Tetrahydrocurcuminoids (THC’s), means that the product is directly assimilated in the body as beneficial metabolites. This is important, as the metabolites are more bioavailable than the parent curcuminoids.
In fact, C3 Reduct® is the only EFSA-approved product of its kind on the market. Other curcumin-based products have to deliver curcumin in large doses to offer functionality. With C3 Reduct® however, manufacturers can avoid the need to up dosages or mix curcumin with other artificial additives to increase bioavailability. This is because C3 Reduct® delivers active metabolites directly to the body.
Curcumin is also yellow in colour, which can lead to staining issues along the production line. C3 Reduct® can also help product developers to overcome this issue, because THCs are colourless. Manufacturers therefore do not have to worry about staining or off-colours.
Post-Covid, consumers are more than ever looking for effective, preventive health solutions that are supported by science. The purpose of this Whitepaper is to help product developers better understand the functional benefits of C3 Reduct®, to identify formulation opportunities and to bring to market health and wellness products that meet consumer demands.
